in3

in3

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Douglas Connect (15 hours ago)
OpenTox Euro 2018 in Athens, Greece - We are pleased to announce that the complete OpenTox Euro 2018 Conference Pro… https://t.co/uIZJVAlkh3
Douglas Connect (4 days ago)
RT @LucianFarcal: Presenting the concept and latest achievements on protocols and data management related to phys-chem characterisation of…
Douglas Connect (5 days ago)
Exploring AI and Machine Learning Approaches to Precision Medicine and Healthcare - Join us for discussion in Phila… https://t.co/2j9ijVonna
Douglas Connect (5 days ago)
Making Evidence-based Decisions in a World of Fake News - how can we better the situation? Scientific research is n… https://t.co/8fqDmryiLW
Douglas Connect (5 days ago)
OpenTox Euro 2018 will commence next month in Athens! The chosen theme for this year's conference will be "Bridging… https://t.co/lPZu5iYV2X

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com